NCT01405495

Brief Summary

The goal of this study is to identify the early modifications in fronto-temporal connectivity in female victims who developed PTSD, compared to female victims who did not develop the disorder, and to healthy control females. The investigators will compare between all these groups, structural and functional differences using different techniques (MRI, fMRI, DTI and ASL), and paradigms (cognitive tasks or at rest).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 7, 2011

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 29, 2011

Completed
6 months until next milestone

Study Start

First participant enrolled

February 1, 2012

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2016

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2016

Completed
Last Updated

May 4, 2017

Status Verified

May 1, 2017

Enrollment Period

4 years

First QC Date

June 7, 2011

Last Update Submit

May 3, 2017

Conditions

Keywords

Posttraumatic Stress DisorderWorking MemoryAttentional BiasConnectivityStructural NeuroimagingFunctional NeuroimagingDiffusion Tensor ImagingArterial Spin LabellingCortisolPsychophysiologyEarly development of

Outcome Measures

Primary Outcomes (1)

  • Changes from baseline brain connectivity in sexual assault female victims who developed PTSD compared to victims without PTSD and healthy control at 6 months.

    We will measure differences in cerebral functional (fMRI) and morphologic (DTI) connectivity during cognitive tasks or at rest in the different groups of participants. It will allow us to understand what are the specific connectivity differences induced by the disorder, but also by the exposition to a traumatic event, compared to healthy controls.

    One month (plus or minus 2 weeks) and 6 months (plus or minus 2 weeks) post trauma

Secondary Outcomes (1)

  • Changes from baseline cerebral activity between groups during cognitive tasks and difference between groups in measures of specific brain structure volumes at 6 months.

    One month (plus or minus 2 weeks) and 6 months (plus or minus 2 weeks) post trauma

Study Arms (3)

PTSD group

Intervention 'MRI-based techniques (sMRI, fMRI, DTI, ASL)'

Procedure: MRI-based techniques (sMRI, fMRI, DTI, ASL)

Exposed without PTSD

Intervention 'MRI-based techniques (sMRI, fMRI, DTI, ASL)'

Procedure: MRI-based techniques (sMRI, fMRI, DTI, ASL)

Healthy Controls

Intervention 'MRI-based techniques (sMRI, fMRI, DTI, ASL)'

Procedure: MRI-based techniques (sMRI, fMRI, DTI, ASL)

Interventions

no drugs include

Also known as: structural magnetic resonance imaging, functional magnetic resonance imaging, diffusion tensor imaging, arterial spin labelling
Exposed without PTSDHealthy ControlsPTSD group

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

PTSD related to sexual abuse vs trauma-exposed vs controls, in right-handed females.

You may qualify if:

  • Written consent
  • affiliated to the National Health Insurance
  • without neurological past history
  • without psychoactive drugs past history

You may not qualify if:

  • the subject can not follow the instructions
  • simultaneous participation to an other study using psychoactive drugs
  • blindness
  • epilepsy
  • addiction to psychoactive drugs
  • MRI counter-indications (pace-makers ...)
  • claustrophobia
  • every circumstances making the subject unable to understand the nature, the objectives or the consequences of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bretonneau Regional Universitary Hospital

Tours, 37044 cedex 9, France

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Salivary cortisol

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Interventions

Diffusion Tensor Imaging

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Intervention Hierarchy (Ancestors)

NeuroimagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisDiffusion Magnetic Resonance ImagingMagnetic Resonance ImagingTomographyDiagnostic Techniques, NeurologicalInvestigative Techniques

Study Officials

  • Wissam El-Hage, MD, PhD

    INSERM U930 Team 4 Affective Disorders

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 7, 2011

First Posted

July 29, 2011

Study Start

February 1, 2012

Primary Completion

February 1, 2016

Study Completion

August 1, 2016

Last Updated

May 4, 2017

Record last verified: 2017-05

Locations